These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10417349)

  • 1. Molecular and functional analysis of mouse decay accelerating factor (CD55).
    Harris CL; Rushmere NK; Morgan BP
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).
    Hinchliffe SJ; Spiller OB; Rushmere NK; Morgan BP
    J Immunol; 1998 Nov; 161(10):5695-703. PubMed ID: 9820551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
    Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
    J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
    Miwa T; Okada N; Okada H
    Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form.
    Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M
    J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional differences among multiple isoforms of guinea pig decay-accelerating factor.
    Wang G; Nonaka M; He C; Okada N; Nakashima I; Okada H
    J Immunol; 1998 Mar; 160(6):3014-22. PubMed ID: 9510206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.
    Ohta R; Imai M; Fukuoka Y; Miwa T; Okada N; Okada H
    Microbiol Immunol; 1999; 43(11):1045-56. PubMed ID: 10609614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decay-accelerating factor in the periovulatory rat ovary.
    Gieske MC; Na GY; Koo Y; Jo M; Curry TE; Ko C
    J Endocrinol; 2005 Aug; 186(2):303-13. PubMed ID: 16079256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms.
    Spicer AP; Seldin MF; Gendler SJ
    J Immunol; 1995 Sep; 155(6):3079-91. PubMed ID: 7545711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor.
    Osuka F; Endo Y; Higuchi M; Suzuki H; Shio Y; Fujiu K; Kanno R; Oishi A; Terashima M; Fujita T; Gotoh M
    Genomics; 2006 Sep; 88(3):316-22. PubMed ID: 16503113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing.
    Nonaka M; Miwa T; Okada N; Nonaka M; Okada H
    J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.
    Miwa T; Sun X; Ohta R; Okada N; Harris CL; Morgan BP; Song WC
    Immunology; 2001 Oct; 104(2):207-14. PubMed ID: 11683961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis.
    Miyagawa S; Fukuta D; Kitano E; Kobayashi C; Fumimoto Y; Shirasu A; Hattori H; Shirakura R; Fukuzawa M
    Xenotransplantation; 2006 Sep; 13(5):433-9. PubMed ID: 16925667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1.
    Shenoy-Scaria AM; Kwong J; Fujita T; Olszowy MW; Shaw AS; Lublin DM
    J Immunol; 1992 Dec; 149(11):3535-41. PubMed ID: 1385527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.
    Nickells MW; Alvarez JI; Lublin DM; Atkinson JP
    J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.
    Moran P; Beasley H; Gorrell A; Martin E; Gribling P; Fuchs H; Gillett N; Burton LE; Caras IW
    J Immunol; 1992 Sep; 149(5):1736-43. PubMed ID: 1380537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
    Qian YM; Haino M; Kelly K; Song WC
    Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.
    Heine H; Ulmer AJ; El-Samalouti VT; Lentschat A; Hamann L
    J Endotoxin Res; 2001; 7(3):227-31. PubMed ID: 11581575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.